This is a Brave Rewards publisher verification file. Domain: huefinancial.com Token: 6398373f459ee8aac7e7ee92eca2f16fa5e2713cfbed3100d69b07a69f6177c1 google-site-verification=OIFzd9VZmCKIIkdj8kgelmd1b_GxU-xz2VhUumtQFCM google.com, pub-2516799717020337, DIRECT, f08c47fec0942fa0 Oppenheimer Maintains Buy Ratings For CBAY Price Target $19

Oppenheimer Maintains Buy Ratings For CBAY Price Target $19


Oppenheimer Maintains a Buy Rating on CymaBay Therapeutics (CBAY) https://www.analystratings.com/articles/oppenheimer-maintains-a-buy-rating-on-cymabay-therapeutics-cbay/


Oppenheimer has a price target for CBAY at $19. Not so fast. The price chart is displaying it will not make it that high. The price chart is showing a price target of $10 - $12, maybe $14.